---
title: "Pre-market hot trades in US stocks: Ionis Pharma pre-market down 10.21%; Fluence Energy pre-market up 7.26%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293467727.md"
description: "Ionis Pharma pre-market down 10.21%; Fluence Energy pre-market up 7.26%; InMed Pharmaceuticals pre-market up 87.67%; Inlif pre-market up 77.58%; China Su Xuan Tang Pharmaceutical pre-market up 57.84%"
datetime: "2026-07-22T11:42:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293467727.md)
  - [en](https://longbridge.com/en/news/293467727.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293467727.md)
---

# Pre-market hot trades in US stocks: Ionis Pharma pre-market down 10.21%; Fluence Energy pre-market up 7.26%

**Pre-market Hot Trades in US Stocks**

Ionis Pharma, down 10.21% in pre-market trading, has no significant news recently. Trading is active with clear capital flow; considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.

Fluence Energy is up 7.26% in pre-market trading. Based on recent key news:

1.  On July 20, Fluence Energy announced it will release its third-quarter financial report for the period ending June 30 on August 5. This news has sparked positive market expectations for the company's performance, driving the stock price up. Source: GlobeNewswire
    
2.  On July 20, Fluence Energy plans to hold an earnings conference call on August 6, and investors are optimistic about the company's future development, further stimulating the stock price rise. Source: GlobeNewswire
    
3.  No other significant news recently. The energy sector has performed strongly lately, with noticeable capital inflow.
    

**Top Gainers in Pre-market US Stocks**

InMed is up 87.67% in pre-market trading. Based on recent key news:

1.  On July 22, InMed Pharmaceuticals released an important announcement that led to a significant increase in stock price. The company published original content via PR Newswire, highlighting major progress in drug development. This news triggered a positive market reaction, pushing the stock price up 87.67% in pre-market trading. The pharmaceutical industry has performed strongly recently, with noticeable capital inflow.

Inlif is up 77.58% in pre-market trading, with no significant news recently. Trading is active with clear capital flow; considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.

China Su Xuan Tang Pharmaceutical is up 57.84% in pre-market trading, with no significant news recently. Trading is active with clear capital flow; considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation

### Related Stocks

- [IONS.US](https://longbridge.com/en/quote/IONS.US.md)
- [FLNC.US](https://longbridge.com/en/quote/FLNC.US.md)
- [INM.US](https://longbridge.com/en/quote/INM.US.md)
- [INLF.US](https://longbridge.com/en/quote/INLF.US.md)
- [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md)

## Related News & Research

- [Ionis Q2 adjusted operating loss narrows](https://longbridge.com/en/news/294198021.md)
- [Entropy Technologies LP Makes New $2.04 Million Investment in Ionis Pharmaceuticals, Inc. $IONS](https://longbridge.com/en/news/293897817.md)
- [Ionis director Michael R. Hayden reports acquisition of 20,000 common shares worth $1,059,000](https://longbridge.com/en/news/294553943.md)
- [Ionis announces Dr. Frank Bennett, chief scientific officer, to retire | IONS Stock News](https://longbridge.com/en/news/294199095.md)
- [U.S. Onshoring Stocks To Watch As Tariff Uncertainty Reshapes Infrastructure Spending](https://longbridge.com/en/news/294146092.md)